title: Red cell lipid peroxidation and antioxidant system in chronic renal failure patients treated with recombinant human erythropoietin.
authors.forename: S
authors.initials: S
authors.lastname: Bozfakioglu
authors.forename: N
authors.initials: N
authors.lastname: Alptekin
authors.forename: S
authors.initials: S
authors.lastname: Seçkin
authors.forename: E
authors.initials: E
authors.lastname: Ark
authors.forename: N
authors.initials: N
authors.lastname: Koçak-Toker
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D004912:Erythrocytes / Q000378:metabolism; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D005978:Glutathione / Q000097:blood; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications; D015227:Lipid Peroxidation; D008297:Male; D008875:Middle Aged
chemical_list: D004921:Erythropoietin; D005978:Glutathione